New Zealand markets closed

Editas Medicine, Inc. (EDIT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.20+0.03 (+0.58%)
At close: 04:00PM EDT
5.22 +0.02 (+0.38%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 428.25M
Enterprise value 166.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.94
Price/book (mrq)1.45
Enterprise value/revenue 2.39
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.08
52-week change 3-44.92%
S&P500 52-week change 323.49%
52-week high 311.91
52-week low 34.91
50-day moving average 36.02
200-day moving average 37.93

Share statistics

Avg vol (3-month) 31.9M
Avg vol (10-day) 31.9M
Shares outstanding 582.24M
Implied shares outstanding 682.24M
Float 876.33M
% held by insiders 10.35%
% held by institutions 186.35%
Shares short (15 May 2024) 420.76M
Short ratio (15 May 2024) 410.96
Short % of float (15 May 2024) 432.01%
Short % of shares outstanding (15 May 2024) 425.25%
Shares short (prior month 15 Apr 2024) 418.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -239.36%
Operating margin (ttm)-5,902.29%

Management effectiveness

Return on assets (ttm)-25.60%
Return on equity (ttm)-54.30%

Income statement

Revenue (ttm)69.41M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)-88.50%
Gross profit (ttm)N/A
EBITDA -179.28M
Net income avi to common (ttm)-166.13M
Diluted EPS (ttm)-2.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)296.17M
Total cash per share (mrq)3.6
Total debt (mrq)34.14M
Total debt/equity (mrq)11.60%
Current ratio (mrq)4.60
Book value per share (mrq)3.58

Cash flow statement

Operating cash flow (ttm)-146.28M
Levered free cash flow (ttm)-89.76M